- Trials with a EudraCT protocol (12)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
12 result(s) found for: Cilostazol.
Displaying page 1 of 1.
EudraCT Number: 2005-002327-13 | Sponsor Protocol Number: 2004VS002 | Start Date*: 2005-07-01 |
Sponsor Name:Heart of England NHS Foundation Trust | ||
Full Title: Mild to moderate intermittent claudication: the clinical and cost-effectiveness of supervised exercise programmes and Cilostazol therapy in patient management | ||
Medical condition: Intermittent claudication | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (GB - no longer in EU/EEA) | ||
Trial results: (No results available) |
EudraCT Number: 2018-001295-37 | Sponsor Protocol Number: CILOGIST | Start Date*: 2018-10-10 |
Sponsor Name:CUB HOPITAL ERASME | ||
Full Title: CILOSTAZOL AS IMATINIB SYNERGISER IN PATIENTS WITH UNRESECTABLE OR METASTATIC GIST TREATED BY GLIVEC® | ||
Medical condition: Gastrointestinal stromal tumors. Gastrointestinal stromal tumors (GISTs) start their development in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: BE (Prematurely Ended) | ||
Trial results: (No results available) |
EudraCT Number: 2020-000661-16 | Sponsor Protocol Number: CGRP2020 | Start Date*: 2020-06-18 | |||||||||||||||||||||
Sponsor Name:Rigshospitalet Glostrup | |||||||||||||||||||||||
Full Title: The effect of anti-calcitonin gene-related peptide (CGRP) receptor antibodies on the headache inducing properties of CGRP and cilostazol in migraine patients | |||||||||||||||||||||||
Medical condition: Migraine | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: DK (Completed) | |||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2010-019977-14 | Sponsor Protocol Number: CILOS-RAY2010 | Start Date*: 2010-11-04 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERA UNIVERSITARIA SAN MARTINO GENOVA | |||||||||||||
Full Title: Efficacy of Cilostazol for the treatment of Raynaud’s Phenomenon in patients affected by Systemic Sclerosis | |||||||||||||
Medical condition: Patients affected by Systemic Sclerosis with Raynaud’s Phenomenon | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-002060-34 | Sponsor Protocol Number: V1.0 | Start Date*: 2008-11-20 |
Sponsor Name:Medizinische Universität Wien; Univ.Klin.f.Innere Med. III, Abt.f.Gastroenterologie u. Hepatologie | ||
Full Title: Impact of Inhibition of Thrombocyte Activation on the course of chronic Hepatitis C | ||
Medical condition: Chronic Hepatitis C | ||
Disease: | ||
Population Age: | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: View results |
EudraCT Number: 2015-001953-33 | Sponsor Protocol Number: PrevSVD-2015 | Start Date*: 2015-10-09 | |||||||||||||||||||||||||||||||
Sponsor Name:University of Edinburgh [...] | |||||||||||||||||||||||||||||||||
Full Title: Preventing cognitive decline and dementia from cerebral small vessel disease | |||||||||||||||||||||||||||||||||
Medical condition: Lacunar (small vessel) ischaemic stroke | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (Completed) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2005-003119-62 | Sponsor Protocol Number: ACT4791 | Start Date*: 2006-02-17 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: Double-blind, double-dummy, randomized, parallel group trial of SL650472 (three dose regimens versus placebo and cilostazol), for 24-week improvement of walking distance in patients with stage II p... | |||||||||||||
Medical condition: Peripheral arterial disease (intermittent claudication) Fontaine stage II | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: CZ (Completed) BE (Completed) SE (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004275-35 | Sponsor Protocol Number: DFI6174 | Start Date*: 2007-01-08 | |||||||||||
Sponsor Name:sanofi-aventis recherche & développement | |||||||||||||
Full Title: A randomized, double-blind, placebo-controlled, parallel group trial of HMR1766 assessing the efficacy and safety of 3 doses of HMR1766 (25, 100, 200 mg OD) versus placebo with cilostazol, 100 mg B... | |||||||||||||
Medical condition: Peripheral Arterial Disease (PAD) Fontaine stage II (intermittent claudication) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) FR (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002277-35 | Sponsor Protocol Number: AC16093 | Start Date*: 2017-06-01 | |||||||||||||||||||||||||||||||
Sponsor Name:University of Edinburgh [...] | |||||||||||||||||||||||||||||||||
Full Title: LACunar Intervention (LACI-2) Trial-2: Assessment of safety and efficacy of cilostazol and isosorbide mononitrate to prevent recurrent lacunar stroke and progression of cerebral small vessel disease. | |||||||||||||||||||||||||||||||||
Medical condition: lacunar (small vessel) ischaemic stroke | |||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2012-000201-72 | Sponsor Protocol Number: 1 | Start Date*: 2012-05-11 |
Sponsor Name:University of Aberdeen [...] | ||
Full Title: The Effects of Inorganic Nitrite on cardiac and skeletal muscle: Physiology, Pharmacology and Therapeutic Potential. Peripheral Arterial Disease | ||
Medical condition: Peripheral arterial Disease | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: GB (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2011-004091-12 | Sponsor Protocol Number: 1204-01 | Start Date*: 2013-01-07 | |||||||||||
Sponsor Name:Pluristem Ltd. | |||||||||||||
Full Title: A Phase II, Randomized, Double-Blind, Multicenter, Multinational, Placebo-Controlled, Parallel-Groups Study to Evaluate the Safety and Efficacy of Intramuscular Injections of Allogeneic PLX-PAD Cel... | |||||||||||||
Medical condition: Intermittent Claudication (IC); Fontaine class IIb; Rutherford category 2-3 | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-000475-27 | Sponsor Protocol Number: I14041 | Start Date*: 2015-07-29 | |||||||||||
Sponsor Name:CHU de Limoges | |||||||||||||
Full Title: Multicenter phase II trial of Nintedanib plus docetaxel in second line of treatment in patients with no squamous non small cell lung cancer refractory to first line chemotherapy (REFRACT study) | |||||||||||||
Medical condition: No squamous non small cell lung | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.